FDA approves Pharming’s Joenja for children with APDS
Pharming said the FDA approved its supplemental New Drug Application for Joenja® as a first treatment for children with APDS in the U.S.
S. Food and Drug Administration approved its supplemental New Drug Application for Joenja in children with APDS. The company made the announcement from Leiden, the Netherlands.